Evaluation of Neurofilament Light Chain as a Biomarker of Neurodegeneration in X-Linked Childhood Cerebral Adrenoleukodystrophy

Comparison of serum neurodegenerative biomarkers among hospitalized COVID‐19 patients versus non‐COVID subjects with normal cognition, mild cognitive impairment, or Alzheimer's dementia

(2022) Jennifer A. Frontera et al.   Alzheimers & Dementia

Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X-linked adrenoleukodystrophy

(2021) Isabelle Weinhofer et al.   Nature Communications

Serum neurofilament light chain in pediatric spinal muscular atrophy patients and healthy children

(2021) Elisa Nitz et al.   Annals of Clinical and Translational Neurology

Neurofilament Light Chain (NfL) in Blood—A Biomarker Predicting Unfavourable Outcome in the Acute Phase and Improvement in the Late Phase after Stroke

(2021) Milos Pekny et al.   Cells

Serum neurofilament light levels in normal aging and their association with morphologic brain changes

(2020) Michael Khalil et al.   Nature Communications

Volume of Gadolinium Enhancement and Successful Repair of the Blood-Brain Barrier in Cerebral Adrenoleukodystrophy

(2020) Troy C. Lund et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

miR-194-5p inhibits LPS-induced astrocytes activation by directly targeting neurexophilin 1

(2020) Ming Wang et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Neurofilament light as a biomarker in traumatic brain injury

(2020) Pashtun Shahim et al.   NEUROLOGY

Successful donor engraftment and repair of the blood brain barrier in cerebral adrenoleukodystrophy

(2019) Paul J. Orchard et al.   BLOOD

Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes

(2019) Edwin Jabbari et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Cerebral adrenoleukodystrophy is associated with loss of tolerance to profilin

(2019) Paul J. Orchard et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years

(2019) Ester Cantó et al.   JAMA Neurology

Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis

(2018) Christian Barro et al.   BRAIN

Neurofilaments as biomarkers in neurological disorders

(2018) Michael Khalil et al.   Nature Reviews Neurology

Glycoprotein NMB: a novel Alzheimer’s disease associated marker expressed in a subset of activated microglia

(2018) Melanie Hüttenrauch et al.   Acta Neuropathologica Communications

Deficiency of α1,6-fucosyltransferase promotes neuroinflammation by increasing the sensitivity of glial cells to inflammatory mediators

(2018) Xu Lu et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls

(2017) Aylin Yilmaz et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy

(2017) Florian Eichler et al.   NEW ENGLAND JOURNAL OF MEDICINE

Identification of a Biomarker in Cerebrospinal Fluid for Neuronopathic Forms of Gaucher Disease

(2015) Hila Zigdon et al.   PLoS One

Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability

(2014) Erika Assarsson et al.   PLoS One

X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management

(2012) Marc Engelen et al.   Orphanet Journal of Rare Diseases

Elevated Cerebral Spinal Fluid Cytokine Levels in Boys with Cerebral Adrenoleukodystrophy Correlates with MRI Severity

(2012) Troy C. Lund et al.   PLoS One

Cerebrospinal Fluid Matrix Metalloproteinases Are Elevated in Cerebral Adrenoleukodystrophy and Correlate with MRI Severity and Neurologic Dysfunction

(2012) Kathryn A. Thibert et al.   PLoS One

Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report

(2011) W. P. Miller et al.   BLOOD

Chitotriosidase as a biomarker of cerebral adrenoleukodystrophy

(2011) Paul J Orchard et al.   Journal of Neuroinflammation

Cysteine-Rich Protein 2, a Novel Downstream Effector of cGMP/cGMP-Dependent Protein Kinase I-Mediated Persistent Inflammatory Pain

(2008) A. Schmidtko et al.   JOURNAL OF NEUROSCIENCE